Prosztatarák: vizsgálatok itt: Ausztrália
81 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleMultimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
- Where
- Sydney
- Életkor
- 18 év and over
- People
- 64
- Run by
- Surgical Outcomes Research Centre (SOuRCe)
See details and how to joinNCT07576335 - 2. fázisTaking peopleStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Camperdown, Melbourne, Parkville, St Albans, Subiaco
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- Pfizer
See details and how to joinNCT04606446 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Birtinya, Blacktown, Brisbane, Camperdown, Concord, Gold Coast, Nedlands, New Lambton Heights, Sydney, Waratah
- Életkor
- 18 év and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - 3. fázisTaking peopleAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Adelaide, Darlinghurst, Herston, Malvern
- Életkor
- 18 év to 100 év
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Brisbane, Clayton, Macquarie University, Melbourne, Westmead
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Auchenflower, Clayton, East Melbourne, Southport, Waratah, Woolloongabba
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Darlinghurst, Kurralta Park, Melbourne, Murdoch
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - 1. fázisTaking peopleA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Where
- East Melbourne
- Életkor
- 18 év and over
- People
- 136 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06879041 - 3. fázisTaking peopleStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Where
- Adelaide, Darlinghurst, Malvern, Murdoch
- Életkor
- 18 év to 100 év
- People
- 940 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06855277 - 1/2. fázisTaking peopleA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
- Where
- Malvern, Melbourne, Murdoch
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07226986 · EU 2025-521859-23-00 - 3. fázisTaking peopleA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Where
- Kingswood, Murdoch, Orange, South Brisbane, St Leonards, Waratah, Woolloongabba
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00 - 3. fázisFut, nem toborozThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Where
- Kurralta Park, Nedlands, Orange, South Brisbane, Wahroonga
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00 - 1/2. fázisNot yet taking people in AusztráliaPhase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Where
- North Adelaide
- Életkor
- 18 év to 99 év
- People
- 152 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07590934 - 1/2. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Where
- Macquarie University
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06863272 · EU 2024-516036-94-00 - 1/2. fázisTaking peopleAn Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
- Where
- Liverpool, Melbourne, St Leonards
- Életkor
- 18 év and over
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07206056 · EU 2025-521880-10-00 - 1/2. fázisTaking peopleFirst-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
- Where
- Darlinghurst, Melbourne
- Életkor
- 18 év to 100 év
- People
- 42 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07529717 - 1. fázisNot yet taking people in AusztráliaA Study of KMV002 in Patients With mAPMR Prostate Cancer
- Where
- East Melbourne, North Ryde
- Életkor
- 18 év to 80 év
- People
- 24
- Run by
- Chimivac INC
See details and how to joinNCT07866300 - 1/2. fázisTaking peopleFOG-001 in Locally Advanced or Metastatic Solid Tumors
- Where
- Melbourne, South Brisbane
- Életkor
- 18 év and over
- People
- 619 worldwide
- Run by
- Parabilis Medicines, Inc.
See details and how to joinNCT05919264 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Darlinghurst, Melbourne, Randwick
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - 1. fázisTaking peoplePhase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Darlinghurst, Liverpool, Macquarie
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Bedford Park, Camperdown, Clayton, Nedlands, South Brisbane
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 3. fázisTaking peopleA Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]
- Where
- Auchenflower
- Életkor
- 18 év and over
- People
- 684 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07802704 · EU 2026-525558-13-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Albury, Birtinya, Brisbane, Saint Leonards, Sydney
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - No phaseTaking peopleBarrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Where
- Fitzroy, Melbourne
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Palette Life Sciences, Inc.
See details and how to joinNCT06496256 - 1. fázisTaking peopleA Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Where
- Bendigo, Douglas, Geelong, Tugun
- Életkor
- 18 év and over
- People
- 83 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07277270 · EU 2025-522274-37-00